Previous 10 | Next 10 |
-- Conference Call Today at 1 PM ET/10 AM PT -- LOS ANGELES, July 17, 2019 (GLOBE NEWSWIRE) -- Capricor ...
Turquoise Hill Resources TRQ -31% after Rio Tinto's Mongolia project expected to be delayed. More news on: China Lending Corporation, Adamis Pharmaceuticals Corporation, Workhorse Group Inc., Stocks on the move, Read more ...
CAPR stock is moving up big as Capricor Therapeutics Inc (NASDAQ:CAPR) announces positive data in a rare disease indication. Big News for Capricor California-based Capricor Therapeutics has been one of the biggest gainers today after the company released positive results from the trial ...
Gainers: Capricor Therapeutics (NASDAQ: CAPR ) +148% . Carolina Trust BancShares (NASDAQ: CART ) +30% . SSLJ.com Limited (YGTY) +29% . Chicken Soup for the Soul Entertainment (NASDAQ: CSSE ) +22% . AVROBIO (NASDAQ: AVRO ) +22% . Mereo BioPharma Group (NASDAQ: MREO ) +21% . Amer...
Capricor Therapeutics (NASDAQ: CAPR ) +95% on positive CAP-1002 data . More news on: Capricor Therapeutics, Inc., Galapagos NV, Neon Therapeutics, Inc., Stocks on the move, Read more ...
Thinly traded nano cap Capricor Therapeutics (NASDAQ: CAPR ) is up 45% premarket on modest volume in response to its announcement of positive six-month data from its Phase 2 clinical trial, HOPE-2 , evaluating lead candidate CAP-1002 in steroid-treated boys and young men with ...
--Interim Analysis Showed Statistically Significant Improvements in the Performance of the Upper Limb, Grip Strength and Inspiratory Flow Reserve in the Randomized Double-Blind Placebo Controlled Study -- --Company to Hold Conference Call Today at 5:00 AM PT / 8:00 AM ET-- ...
Capricor Therapeutics, Inc. (CAPR) Q1 2019 Earnings Conference Call May 13, 2019, 04:30 PM ET Company Participants AJ Bergmann - CFO Linda Marbán - President and CEO Conference Call Participants Joe Pantginis - H.C. Wainwright Jason McCarthy - Maxim Group Presentati...
Capricor Therapeutics (NASDAQ: CAPR ) Q1 highlights : More news on: Capricor Therapeutics, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Capricor Therapeutics (NASDAQ: CAPR ): Q1 GAAP EPS of -$0.08 beats by $0.03 . More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is set to join the Russell 2000 ® Index an...
-Results in Performance of the Upper Limb (PUL v2.0) Continue to Show Slowing of Disease Progression in Later-Stage DMD Patients- -Improvements Seen in Multiple Cardiac Endpoints Demonstrating Stabilization of Cardiac Function Over 3 Years of Treatment- -Pre-BLA Meeting with FDA...
SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- In a release issued under the headline "Capricor Therapeutics Announces for the Treatment of Duchenne Muscular Dystrophy" on Tuesday, June 25th by Capricor Therapeutics, please note that the words "Pre-BLA Meeting with FDA for Deramiocel" were omitted ...